Insiders · Profile

Brophy Gerard

EVP, Biopharma Production at Avantor. Filing since 20 May 2020. CIK 0001776107

Company
Date
Role
Action
Shares
Amount
Of holding
3 Mar 2023
EVP, Biopharma Production
Sold, plan not stated
3,914
$97.85K
3.5%
27 Feb 2023
EVP, Biopharma Production
Sold, plan not stated
3,059
$76.48K
2.6%
2 Feb 2023
EVP, Biopharma Production
Sold, plan not stated
11,339
$284.16K
10.0%
20 May 2022
EVP, Biopharma Production
Sold, plan not stated
19,603
$612.99K
16.8%
1 Mar 2022
EVP, Biopharma Production
Sold, plan not stated
2,027
$69.87K
1.5%
23 Feb 2022
EVP, Biopharma Production
Sold, plan not stated
3,059
$103.36K
2.4%
5 Jan 2022
EVP, Biopharma Production
Sold, plan not stated
11,551
$446.45K
8.1%
3 Jan 2022
EVP, Biopharma Production
Sold, plan not stated
59,418
$2.42M
29.4%
30 Jul 2021
EVP, Biopharma Production
Sold, plan not stated
81,125
$3.02M
35.2%
20 May 2021
EVP, Biopharma Production
Sold, plan not stated
19,603
$609.65K
11.6%
24 Feb 2021
EVP, Biopharma Production
Sold, plan not stated
3,059
$85.44K
1.7%
22 Feb 2021
EVP, Biopharma Production
Sold, plan not stated
19,769
$565.79K
10.1%
11 Jan 2021
EVP, Biopharma Production
Sold, plan not stated
378,580
$11.38M
68.0%
6 Jan 2021
EVP, Biopharma Production
Sold, plan not stated
11,509
$313.51K
6.1%
4 Jan 2021
EVP, Biopharma Production
Sold, plan not stated
59,418
$1.65M
23.8%
20 May 2020
EVP, Biopharma Production
Sold, plan not stated
25,495
$442.59K
11.5%
16 decisions on file.